Share

Trump's week in review: Middle East trip, trade deal with China, investigating the abortion pill

By Ryan Foley, Christian Post Reporter
The U.S. Department of Health and Human Services building is shown August 16, 2006, in Washington, D.C. The HHS building, also known as the Hubert H. Humphrey building, is located at the foot of Capitol Hill and is named for Humphrey, who served as a U.S. senator from Minnesota and vice president of the United States.
The U.S. Department of Health and Human Services building is shown August 16, 2006, in Washington, D.C. The HHS building, also known as the Hubert H. Humphrey building, is located at the foot of Capitol Hill and is named for Humphrey, who served as a U.S. senator from Minnesota and vice president of the United States. | Mark Wilson/Getty Images
2. HHS investigates hospital over abortions, commits to reviewing the abortion pill 

In a statement published Monday, the U.S. Department of Health and Human Services announced that it is investigating an unnamed hospital to ensure that it's complying with federal law protecting conscience rights for healthcare providers. 

Shortly thereafter, the American Center for Law and Justice confirmed that it had been in contact with the agency on behalf of five of its clients, ultrasound technicians at Presbyterian Hospital in Albuquerque, New Mexico. 

"After we took action on behalf of five ultrasound technicians in New Mexico who were concerned that they would soon be forced to participate in abortion procedures despite their deeply held religious beliefs, the federal government has now launched a formal investigation into the hospital's conduct," said ACLJ Executive Director Jordan Sekulow in a statement published Tuesday. 

When testifying on Capitol Hill Wednesday, HHS Secretary Robert F. Kennedy Jr. assured Sen. Josh Hawley, R-Mo., that he ordered Marty Makary of the Food and Drug Administration to conduct a "top-to-bottom review" of the abortion pill mifepristone following the publication of what Kennedy described as an "alarming" report from the Ethics and Public Policy Center indicating that more than 10% of women who take the abortion pill experience adverse effects. 

Kennedy suggested that "at the very least, the label should be changed," referring to the label that accompanies the drug stating, "Serious adverse reactions were reported in <0.5% of women." The HHS secretary indicated that he may reinstate safety protocols for the abortion pill removed by the Biden and Obama administrations, depending on what recommendations Makary makes. 

Ryan Foley is a reporter for The Christian Post. He can be reached at: ryan.foley@christianpost.com

You’ve readarticles in the last 30 days.

Was this article helpful?

Help keep The Christian Post free for everyone.

Our work is made possible by the generosity of supporters like you. Your contributions empower us to continue breaking stories that matter, providing clarity from a biblical worldview, and standing for truth in an era of competing narratives.

By making a recurring donation or a one-time donation of any amount, you’re helping to keep CP’s articles free and accessible for everyone.

We’re sorry to hear that.

Hope you’ll give us another try and check out some other articles. Return to homepage.

Most Popular